Centessa Pharmaceuticals is making waves in the biopharma sphere with a potential 44% upside, targeting a price of $22.00 per share. Their lead candidate, ORX750, aims to tackle narcolepsy and...
The question of whether Jerome Powell should step down as Chair of the Federal Reserve has surfaced with renewed intensity in financial circles during July 2025. A prominent economist, Mohamed...
Key Takeaways Target’s stock declined approximately 27% in the first half of 2025, testing a critical technical support level around $104 amid weakening consumer sentiment. First-quarter 2025 results revealed declining...
Key Takeaways Bitcoin’s market dominance stands at approximately 54% in mid-2025, a retreat from its 2024 peak but still a significant share of the total crypto market capitalisation. Historical data...
Key Takeaways xAI is reportedly seeking an additional $10 billion to $12 billion in funding, on top of its recent $6 billion Series B raise, to fuel a massive expansion...
The possibility of a high-level meeting between US President Donald Trump and Chinese President Xi Jinping in the coming months has emerged as a focal point for global markets, with...
Key Takeaways AMD’s Instinct MI300 series has driven significant data centre growth, surpassing $1 billion in cumulative sales within two quarters of its launch. Wall Street projects AMD’s AI GPU...
Key Takeaways Intuitive Machines (LUNR) is positioned as a key beneficiary of the burgeoning lunar economy, driven by geopolitical competition between the US and China and the push for a...
Key Takeaways Netflix has revised its full-year 2025 revenue forecast upwards to between $44.8 billion and $45.2 billion, largely driven by favourable currency effects from a weakening US dollar. Despite...
Key Takeaways General Motors anticipates a tariff-related cost burden of £3.2 billion to £4 billion for the full year 2025, significantly impacting its financial outlook. The company has lowered its...
